This pilot study will investigate the pathogenesis of the diabetes associated with protease inhibitor treatment. Diabetes develops in a certain percentage of HIV infected patients treated with protease inhibitors (Indinavir, Saquinavir, ritonavir and nelfinavir). In patients without pre-existing diabetes the onset of hyperglycemia occurred as early as 4 days to as late as seven months after starting therapy, with an average of 76 days. There seem to be no dose relationships.
Showing the most recent 10 out of 509 publications